Header image

Dennis Quaid recently testified before Congress regarding the near fatal ovedose of his newborn twins at Cedar Sinai Medical Center in Los Angeles. See his testimony here on YouTube. Mr. Quaid testified very effectively on the need for FDA recalls of Heparin and the need to keep the path to the courthouse open for families devastated by medical negligence.Please, take the time to listen to Dennis Quaid’s story and his argument that the Supreme Court and Congress should not protect a drug company from liability because the drug and the labeling was approved by the FDA.

Despite massive publicity, hospitals continue to mistakenly give infants adult doses of Heparin, a blood thinner. As reported by The Institute for Safe Medication Practices a Nebraska hospital has administered a deadly dose of Heparin, this time to a toddler about to celebrate her second birthday. The dose of blood thinner led to cerebral bleeding and brain death.This is by no means the first case and is far from the most famous. As I wrote in March 2008, actor Dennis Quaid’s new born twins were given near-lethal doses of adult formulated heparin at Cedars-Sinai Medical Center in Beverly Hills. See Celebrity Cases Highlight Medical Negligence Issues. Despite the massive publicity surrounding the incident and subsequent legal action, many hospitals have failed to take the necessary precautions and implement procedures to prevent continuing injuries and deaths.Heparin should be deemed a “high-alert medication” and special precautions should be instituted in every hospital to prevent dosing errors. As the Institute for Safe Medication Practices has reported for years, Heparin has repeatedly been among the top 10 drugs involved in serious, preventable injuries, disabilities and deaths reported to the Federal Drug Administration.If you suspect that you or a family injury has been harmed by an improper dose of Heparin, contact an experienced medical malpractice attorney immediately. In Missouri and Illinois, contact Todd N. Hendrickson. I will personally review your case.

DePuy, a division of Johnson & Johnson that manufactures orthopedic implants, including hip implant replacement systems, has withdrawn its ASR metal-on-metal implants, reports the New York Times. DePuy has touted this as its way of protecting patient safety, but in truth, evidence suggests that DePuy has known of this problem for years.

DePuy has informed doctors in a letter that the ASR had a higher-than-expected failure rate in certain types of patients. Data from a study out of Australia suggests that small statured patients, such as women, are at the highest risk. DePuy seems to indicate that the problem lies in how surgeons are installing the implants.

However, evidence suggests that the metal-an-metal implants can generate large amounts of metallic debris as they wear. This debris can cause severe inflammatory responses in some patients, damage muscles, soft tissue and bone. These reactions can lead to early need to replace the implants through revision surgery, in some cases in as little as 2 years. The normal expected life of such implants is 15 years and more.

Many implant manufactures began offering metal-on-metal implants a number of years ago as alternatives to the polyethylene (plastic) or ceramic components. With the metal-on-metal, both the ball and the cup (socket) are made from metal and, as they wear, they give off metal shavings and residue.

At this time it appears that DePuy and possibly other manufacturers did not sufficiently test these implant materials and, even after learning of unusually high failure rates, continued to actively market and promote the product. If you have had an implant fail within a few years after your surgery, you should immediately contact Todd N. Hendrickson. Our office specializes in medical malpractice and medical product liability claims and can help you fight for your rights. Call our office at 314-721-8833 for a free consultation.